Named as a key player in 1,254 of our reports, across 33 regions and countries.
[1] ClinicalTrials.gov, Studies led by GE Healthcare or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Our reports that name GE Healthcare as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as GE Healthcare (number of shared markets).
Philips Healthcare20 shared markets
Siemens Healthineers19 shared markets
Medtronic11 shared markets
IBM Watson Health9 shared markets
NVIDIA Corporation8 shared markets
Koninklijke Philips N.V.7 shared markets
Cerner Corporation5 shared markets
McKesson Corporation5 shared markets
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Source: SEC EDGAR, Company filings, CIK 40545. Retrieved 13 Nov 2026.
22 active studies led by GE Healthcare, of 176 in all
Source: ClinicalTrials.gov, Studies with GE Healthcare (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
16 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
100 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Includes GE Healthcare Finland Oy, Ge Healthcare Japan Corporation. Retrieved 13 Nov 2026.
457 recalls since 2015 (457 for devices)
Source: openFDA, FDA enforcement reports (recalls) naming the firm, since 2015. Includes GE Healthcare Finland Oy, Ge Healthcare Japan Corporation. Retrieved 13 Nov 2026.
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 40545.
Studies GE Healthcare leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with GE Healthcare or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show GE Healthcare: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets GE Healthcare is in.
Stories on the topics GE Healthcare works in.
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Behind every insurance claim is a standard electronic message. The CAQH Index says $20 billion a year could…
Read
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read